| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.100 | None | 0.857 | 28 | 1 | 1997 | 2019 | ||||||||
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.100 | None | 1.000 | 21 | 2 | 2013 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.100 | None | 0.895 | 19 | 2 | 1995 | 2019 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.100 | None | 0.750 | 16 | 4 | 2001 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
disease | 0.100 | None | 0.667 | 12 | 2 | 2000 | 2015 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.100 | None | 0.900 | 10 | 3 | 2000 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.090 | None | 0.889 | 9 | 2 | 2001 | 2009 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.080 | None | 0.750 | 8 | 3 | 2003 | 2016 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.060 | None | 0.500 | 6 | 3 | 2004 | 2014 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
disease | 0.050 | None | 0.800 | 5 | 3 | 2004 | 2012 | ||||||||
|
heparan sulfate proteoglycan 2 | 0.438 | 0.885 | 1.0E-19 |
|
disease | 0.050 | None | 1.000 | 5 | 2 | 2010 | 2019 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2003 | 2009 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1982 | 2017 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2000 | 2012 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2011 | 2017 | ||||||||
|
peptidylprolyl isomerase G | 0.497 | 0.846 | 0.96 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2005 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2006 | ||||||||
|
phosphodiesterase 4B | 0.566 | 0.731 | 0.47 |
|
disease | 0.020 | None | 0.500 | 2 | 4 | 2010 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.020 | None | < 0.001 | 2 | 1 | 2008 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2005 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2007 | 2012 | ||||||||
|
glutathione peroxidase 1 | 0.458 | 0.923 | 3.9E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2006 | 2010 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2004 | 2004 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2006 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2000 | 2004 |